SPDR® S&P Biotech ETF (XBI)

Delayed Data
As of 6:38pm ET
 -3.09 / -2.00%
Today’s Change
Today|||52-Week Range

Investment Objective

The investment seeks to provide investment results that, before fees and expenses, correspond generally to the total return performance of the S&P Biotechnology Select Industry Index derived from the biotechnology segment of a U.S. total market composite index. In seeking to track the performance of the S&P Biotechnology Select Industry Index (the "index"), the fund employs a sampling strategy. It generally invests substantially all, but at least 80%, of its total assets in the securities comprising the index. The index represents the biotechnology segment of the S&P Total Market Index ("S&P TMI").

Is Gilead Sciences Stock a Buy?
6:14am / MotleyFool.com - Paid Partner Content
Why I'm Betting Big on This 1 Megatrend
Jan 25 / MotleyFool.com - Paid Partner Content
Can Moderna ETFs Gain on COVID Vaccine Update Against Variants?
Jan 26 / Zacks.com - Paid Partner Content


1 month+3.05% 3 years+17.21%
3 months+33.15% 5 years+23.60%
1 year+70.46% Since inception+16.45%
Data through 01/27/2021

Quote Details

Previous close$154.38
Open day’s range148.90 – 158.96
Net asset value (NAV)154.35 (01/26/2021)
Daily volume8,656,056
Average volume (3 months)4,616,494
Data as of 6:38pm ET, 01/27/2021

Peer Comparisonvs. Health ETFs

Performance 5-yr return+23.60%+11.77%
Expense Gross exp ratio0.35%1.21%
Risk 5 year sharpe ratio0.570.61
Net assets$7.0B$3.8B
Average market cap$3.5B$39.9B
Average P/E--28.6
Dividend / Share--0.32%


VHT Vanguard Health Care Index Fund ETF Shar...
FHLC Fidelity MSCI Health Care Index ETF
PSCH Invesco S&P SmallCap Health Care ETF


Top 5 Sectors
Portfolio weighting
Healthcare 100.00%
Business service 0.00%
Consumer goods 0.00%
Consumer service 0.00%
Energy 0.00%
Top 10 Holdings
Portfolio weighting
ALXN Alexion Pharmaceuticals Inc1.17%
AGIO Agios Pharmaceuticals Inc1.17%
SAGE SAGE Therapeutics Inc1.14%
IONS Ionis Pharmaceuticals Inc1.12%
TGTX TG Therapeutics Inc1.12%
KOD Kodiak Sciences Inc1.06%
BBIO BridgeBio Pharma Inc1.05%
APLS Apellis Pharmaceuticals Inc1.04%
EDIT Editas Medicine Inc1.03%
ARNA Arena Pharmaceuticals Inc1.01%